SPARKS, Nevada, December 6, 2017 /PRNewswire/ --
RESTANCE, Inc. (USOTC: ANCE) today announced an online presentationscheduled for release tomorrow detailing the company's global brand name partnership strategy for implementing highly profitable, socially responsible development projects in Africa. RESTANCE recently announced
In addition to opening a condom manufacturing plant, RESTANCE is pursuing several other business lines in the growing economies of East Africa. The Company is developing opportunities in the region including initiatives in technology and systems integration services, utility support services, affordable housing and health products manufacturing. RESTANCE recently acquired East African Development Partners as part of its strategy in East Africa.
Learn more about the RESTANCE operations in Africa on the Company's website: http://www.restanceinc.com
This news release contains forward-looking statements within the meaning of the Securities Litigation Reform Act. The statements reflect the Company's current views with respect to future events that involve risks and uncertainties. Among others, these risks include the expectation that any of the companies mentioned herein will achieve significant sales, the failure to meet schedule or performance requirements of the companies' contracts, the companies' liquidity position, the companies' ability to obtain new contracts, the emergence of competitors with greater financial resources and the impact of competitive pricing. In the light of these uncertainties, the forward-looking events referred to in this release might not occur.
Randell Torno email@example.com +1-800-834-5792
SOURCE RESTANCE, Inc.
Subscribe to our Free Newsletters!
FDA recently approved Mogamulizumab-kpkc, a human monoclonal antibody prescribed for adult ...
Birth Control Implant is a long-acting birth control contraceptive inserted into the arm. It is a ...
Mastocytosis is a rare condition marked by accumulation of mast cells under the skin and various ...View All